These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53. [Physiopathology of the dyskinesias induced by L-dopa]. Grandas F; López-Ariztegui N Rev Neurol; 1997 Aug; 25 Suppl 2():S151-6. PubMed ID: 9280682 [TBL] [Abstract][Full Text] [Related]
54. [Tardive dyskinesias of neuroleptics. Major complications of long-term neuroleptic treatment]. Bourgeois M Ann Med Psychol (Paris); 1987 Feb; 145(2):156-60. PubMed ID: 2887139 [No Abstract] [Full Text] [Related]
55. Prevention and management of tardive dyskinesia. Jeste DV; Wyatt RJ J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473 [TBL] [Abstract][Full Text] [Related]
56. Clinical and neurobiologic implications of antipsychotic-induced movement disorders. Rubin EH; Zorumski CF Compr Ther; 1986 Oct; 12(10):61-7. PubMed ID: 2877769 [No Abstract] [Full Text] [Related]
57. [Spontaneous facial-buccal-lingual dyskinesia: clinical studies and pharmacological experiments]. Serra S; di Rosa AE Acta Neurol (Napoli); 1975; 30(6):576-86. PubMed ID: 3950 [No Abstract] [Full Text] [Related]